[1]TORO A, MAHFOUZ AE, ARDIRI A, et al.What is changing in indications and treatment of hepatic hemangiomas.A review[J].Ann Hepatol, 2014, 13 (4) :327-339.
|
[2]ZOU H, MA KS.Current situation on radiofrequency ablation of hepatic hemangioma[J].J Clin Hepatol, 2013, 29 (8) :567-569. (in Chinese) 邹华, 马宽生.射频消融治疗肝血管瘤的现状[J].临床肝胆病杂志, 2013, 29 (8) :567-569.
|
[3]GIULIANTE F, ARDITO F, VELLONE M, et al.Reappraisal of surgical indications and approach for liver hemangioma:singlecenter experience on 74 patients[J].Am J Surg, 2011, 201 (6) :741-748.
|
[4]DONATI M, STAVROU GA, DONATI A, et al.The risk of spontaneous rupuure of liver hemangioma:a critical review of the literature[J].J Gastrointest Surg, 2011, 15 (1) :209-214.
|
[5]GAO J, SUN WB.Modern views on surgical treatment of hepatic hemangioma[J].Chin J Med, 2014, 49 (12) :13-15. (in Chinese) 高君, 孙文兵.肝血管瘤外科治疗的现代观[J].中国医刊, 2014, 49 (12) :13-15.
|
[6]WU ZB, HUANG ZY.Indications and methods for surgical treatment of hepatic hemangioma[J].J Clin Surg, 2014, 22 (8) :616-618. (in Chinese) 吴珍宝, 黄志勇.肝血管瘤外科治疗的指征与方法[J].临床外科杂志, 2014, 22 (8) :616-618.
|
[7]SCHNELLDORFER T, WARE AL, SMOOT R, et al.Management of giant hemangioma of the liver:resection versus observation[J].J Am Coll Surg, 2010, 211 (6) :724-730.
|
[8]YEDIBELA S, ALIBEK S, MULLER V, et al.Management of hemangioma of the liver:surgical therapy on observation?[J].World J Surg, 2013, 37 (6) :1303-1312.
|
[9]WAGN KY, FU HQ.Surgical treatment and operative indication of hepatic hemangioma[J].Chin J Hepatobiliary Surg, 2011, 17 (9) :701-702. (in Chinese) 王开阳, 傅华群.肝血管瘤的外科治疗现状及手术指征[J].中华肝胆外科杂志, 2011, 17 (9) :701-702.
|
[10]DONG J, ZHU Y, WANG WL, et al.Hepatic hemangoma treated by surgical resection:a analysis of 128 patients[J].Chin J Hepatobiliary Surg, 2014, 20 (8) :595-598. (in Chinese) 董建, 朱迎, 王万里, 等.肝血管瘤128例外科治疗分析[J].中华肝胆外科杂志, 2014, 20 (8) :595-598.
|
[11]LERNER SM, HIATT JR, SALAMANDRA J, et al.Giant cavernous liver hemangiomas:effect of operative approach on outcome[J].Arch Surg, 2004, 139 (8) :818-821, 821-823.
|
[12]CHENG JJ, MA JL.Treatment progress in adult hepatic cavernous hemangioma[J].Med Recapitulate, 2013, 19 (11) :2020-2022. (in Chinese) 程炯炯, 马金良.成人肝海绵状血管瘤的治疗进展[J].医学综述, 2013, 19 (11) :2020-2022.
|
[13]DOU KF, JIN C.Prowess in surgery for hemangioma of liver[J].Chin J Dig Surg, 2013, 12 (1) :13-15. (in Chinese) 窦科峰, 金成.肝血管瘤外科治疗进展[J].中华消化外科杂志, 2013, 12 (1) :13-15.
|
[14]ZHOU CM, ZHANG JH, REN WX, et al.Treatment and clinical grading system of liver hemangioma among 514 patients[J].Chin J Dig Surg, 2015, 14 (2) :102-105. (in Chinese) 周成明, 张金辉, 任伟新, 等.514例肝血管瘤的治疗与临床评分[J].中华消化外科杂志, 2015, 14 (2) :102-105.
|
[15]ZHU Q, QIAO GL, YAN JJ, et al.New perspectives on the natural history and growth pattern of hepatic hemangioma in adults:a cohort study[J].Chin J Hepatobiliary Surg, 2015, 21 (11) :721-725. (in Chinese) 朱倩, 乔国梁, 晏建军, 等.对成人肝血管瘤自然发展进程及生长方式的新认识:队列研究[J].中华肝胆外科杂志, 2015, 21 (11) :721-725.
|
[16]GENG XP.Hepatic hemangioma and precise surgical treatment[J].Chin J Bases Clin Gen Surg, 2016, 23 (2) :137-139. (in Chinese) 耿小平.肝血管瘤与精准外科治疗[J].中国普外基础与临床杂志, 2016, 23 (2) :137-139.
|
[17]QIU MQ.Comparison of curative effect by resection of hepatic hemangioma and traditional operation of stripping[J].China Med Herald, 2014, 11 (19) :65-68. (in Chinese) 邱明权.肝血管瘤传统手术切除和剥离术疗效对比[J].中国医药导报, 2014, 11 (19) :65-68.
|
[18]MUAMMADCUMA DX, WEN H.Advances in surgical diagnosis and treatment of hepatic hemangioma[J].Xinjiang Med J, 2011, 41 (1) :91-95. (in Chinese) 买买提居马·对先, 温浩.肝血管瘤外科诊治进展[J].新疆医学, 2011, 41 (1) :91-95.
|
[19]QIN XL, XU J, DI WD, et al.Laparoscopic treatment of hepatic hemangioma on the operation method and curative effect of comparative analysis[J/CD].Chin J Laparoscopic Surgery:Electronic Edition, 2014, 7 (5) :350-353. (in Chinese) 秦学良, 徐钧, 底卫东, 等.腹腔镜治疗肝血管瘤手术方式选择及疗效的比较分析[J/CD].中华腔镜外科杂志:电子版, 2014, 7 (5) :350-353.
|
[20]WU X, XIA H, WU J, et al.Clinical experience in treatment of complex intrahepatic bile duct stones by regular hepatectomy[J].J Clin Hepatol, 2016, 32 (9) :1756-1759. (in Chinese) 吴晓, 夏灏, 吴健, 等.规则肝切除术治疗复杂肝内胆管结石的临床体会[J].临床肝胆病杂志, 2016, 32 (9) :1756-1759.
|
[21]LI LH, WANG JW, LIU B, et al.Clinical application of three-dimensional reconstruction in preoperative evaluation of hepatectomy[J].J Clin Hepatol, 2016, 32 (5) :938-941. (in Chinese) 李连海, 王建伟, 刘斌, 等.三维重建在肝切除术前评估中的临床应用效果[J].临床肝胆病杂志, 2016, 32 (5) :938-941.
|
1. | 温芳芳,张龙,王娟. 预后营养指数、血清白蛋白对肝切除术病人术后感染风险的预测价值及护理指导意义. 全科护理. 2025(02): 236-239 . ![]() | |
2. | 魏红艳,王远珍,常丽仙,木唤,刘春云,刘立. 原发性肝癌合并腹水患者发生SBP的风险预测分析. 昆明医科大学学报. 2024(03): 133-140 . ![]() | |
3. | 魏红艳,王远珍,常丽仙,木唤,刘春云,刘立. 原发性肝癌患者并发自发性腹膜炎临床诊断模型的构建和应用. 现代肿瘤医学. 2024(19): 3718-3725 . ![]() | |
4. | 朱明强,杨大帅,熊祥云,裴俊鹏,彭阳,丁佑铭. 肝癌肝切除术后感染风险预测模型的建立与评价. 临床肝胆病杂志. 2023(01): 110-117 . ![]() | |
5. | 罗清兰,邓宇伟,曾涛. 原发性肝癌术前中性粒细胞/淋巴细胞比值、血小板/淋巴细胞比值和甲胎蛋白对预后的评估分析. 当代医学. 2022(19): 18-21 . ![]() | |
6. | 付先锋,晏燕. 肝动脉介入栓塞治疗的肝癌患者预后与血清胆碱酯酶、钠水平的关系分析. 检验医学与临床. 2022(24): 3417-3420 . ![]() | |
7. | 曾桥. 腹腔镜手术治疗肝癌的分析. 当代医学. 2021(04): 96-98 . ![]() | |
8. | 黄旦华. 多项肿瘤标志物联合检测在肝癌中的诊断效能. 医疗装备. 2021(11): 52-53 . ![]() | |
9. | 袁维,孙克伟,陈斌,朱文芳,银思涵. 56例中晚期原发性肝癌死亡患者的临床分析. 中西医结合肝病杂志. 2021(08): 707-711 . ![]() | |
10. | 马冰,白黎,赵艳,海丹丹,李花花. 原发性肝癌TACE术后发生感染性并发症的影响因素研究. 实用癌症杂志. 2021(12): 2033-2035 . ![]() | |
11. | 王益卓,刘唯佳,卢兵,黄其密,唐德奉. 原发性肝癌合并肺部感染58例临床特征分析. 中华肺部疾病杂志(电子版). 2020(01): 83-84 . ![]() | |
12. | 刘娟. 以坚强概念为基础的心理干预对原发性肝癌合并抑郁病人症状改善、心理状态及生命质量的影响. 全科护理. 2020(28): 3834-3837 . ![]() | |
13. | 叶颖剑,刘波,陈伟,李琼霞. 血清AFP阴性的肝细胞癌患者预后及分期系统分析. 临床肝胆病杂志. 2019(03): 535-541 . ![]() |